How Ashwagandha Lowers Cortisol
Ashwagandha lowers cortisol primarily by modulating the hypothalamic-pituitary-adrenal (HPA) axis, resulting in reduced cortisol secretion and improved stress response regulation. 1, 2, 3
Mechanism of Action
The cortisol-lowering effect operates through HPA axis normalization. Ashwagandha's active compounds—particularly withanolide glycosides—act on the hypothalamus and pituitary gland to reduce the stress-induced activation cascade that triggers cortisol release from the adrenal cortex 2. This adaptogenic mechanism helps restore the body's normal circadian cortisol rhythm rather than simply suppressing cortisol production 3.
Key Mechanistic Pathways:
- HPA axis modulation: The primary mechanism involves dampening excessive hypothalamic-pituitary signaling that drives adrenal cortisol secretion 2, 3
- Stress reactivity attenuation: Ashwagandha stabilizes cortisol responses during acute stress challenges, preventing excessive cortisol spikes 4
- Neuroinflammation reduction: Secondary effects include decreased neuroinflammation and enhanced GABAergic activity, which indirectly support HPA axis regulation 5
Clinical Evidence of Cortisol Reduction
The most recent meta-analysis demonstrates robust cortisol-lowering effects with a standardized mean difference of -1.18 (p < 0.04) 1. Individual trials show even more dramatic reductions:
- 66-67% reduction in morning serum cortisol with 60-120 mg daily of high-withanolide extract (35% withanolide glycosides) over 60 days 6
- Pooled cortisol reduction of -3.27 µg/dL across multiple studies 5
- Stabilization of cortisol reactivity during acute stress testing, where placebo groups showed increased cortisol but ashwagandha groups maintained stable levels 4
Dose-Response Considerations:
The evidence suggests withanolide content matters more than total extract dose. Studies using 30-120 mg of high-withanolide extracts (35% withanolide glycosides) showed comparable or superior effects to studies using 240-600 mg of standard extracts 6, 4. This indicates the active withanolide compounds are the primary drivers of cortisol modulation 1.
Physiological Context
Understanding cortisol's normal physiology helps contextualize ashwagandha's effects. Cortisol follows a circadian rhythm with peak levels upon waking and a nadir at night 7, 8. Chronic stress disrupts this pattern, leading to elevated baseline cortisol and loss of normal circadian variation. Ashwagandha appears to restore this physiological pattern rather than indiscriminately suppressing cortisol 3.
Important Caveats:
- The cortisol-lowering effect is most pronounced in individuals with elevated baseline stress and cortisol levels 6, 3
- Athletes during high-intensity training periods show stabilization of stress biomarkers rather than absolute suppression 9
- Effects manifest over 4-8 weeks of consistent supplementation, not acutely 6, 3
Secondary Hormonal Effects
Beyond cortisol reduction, ashwagandha influences other hormones through HPA axis modulation:
- DHEA-S reduction: Decreased by similar magnitude as cortisol, suggesting coordinated adrenal regulation 3
- Testosterone increase: Particularly in males (22-33% increase), likely secondary to reduced cortisol's inhibitory effect on gonadal function 1, 6
- No effect on thyroid axis: Despite some claims, the meta-analysis found no significant TSH or T3 changes, only modest T4 elevation 1
Clinical Implications
For stress-related cortisol elevation, ashwagandha at 60-120 mg daily (standardized to 35% withanolide glycosides) or 240-600 mg of standard extract provides clinically meaningful cortisol reduction over 4-8 weeks 1, 5, 6. The mechanism—HPA axis modulation—means this is a regulatory effect rather than pharmacologic suppression, which explains the favorable safety profile across trials 5.
The evidence quality is moderate (GRADE assessment) with low risk of bias in approximately one-third of trials 5. The most recent 2026 meta-analysis 1 and systematic review 5 provide the strongest synthesis of this mechanism, supported by consistent findings across multiple randomized controlled trials.